Register
Login

Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Welcome to the latest edition of touchREVIEWS in Infectious Diseases, where we continue our mission to deliver insightful, cutting-edge perspectives in infectious disease diagnosis and management. This issue offers an array of topics spanning diagnostics, service delivery innovations and preventive care, reflecting the dynamic challenges and opportunities in our field. In our first editorial, Barbara […]

Lisa Catalli, ACTHIV 2021: Hepatitis C and HIV Co-infection

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 10th 2021

It was a pleasure to speak with Lisa Catalli (Department of GI/Hepatology, UCSF Medical Center, University of California, San Francisco, CA, USA) to discuss practical advice and diagnostic tools for hepatitis C and HIV treatment.

The abstract entitled: ‘Pre-Treatment Evaluation of Hepatitis C in HIV and On-Treatment Management Cases’ was presented at the ACTHIV Virtual Conference 2021, May 20-22, 2021.

Questions:

  1.  What information is needed when conducting an HCV-focussed evaluation and work up for direct acting antiviral therapy? (0:10)
  2.  What tools can predict cirrhosis and what are the next steps if cirrhosis is predicted? (1:13)
  3. What tools are available to guide HCV treatment? (3:00)
  4. What other advice would you give to practitioners when facing the challenges of HCV-HIV coinfection? (3:50)

Disclosures: Lisa Catalli has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media.

Filmed in coverage of the ACTHIV Virtual Conference 2021.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup